Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Sanofi Expands Medidata Cloud Platform | Contract Pharma

What are you searching for?

Sign in
Breaking News

Sanofi Expands Medidata Cloud Platform

Leverages RaveTSDV technology for risk-based monitoring of clinical trial sites

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Sanofi has increased its adoption of the Medidata Clinical Cloud as part of a company-wide initiative aimed at increasing productivity across its global R&D organization. Sanofi will now leverage Miedidata’s technology for risk-based monitoring of clinical trial sites, in addition to the solutions and analytics currently used.
 
Sanofi is developing an industry-wide approach for targeted monitoring of clinical trial sites and has selected Medidata’s targeted source document verification, Medidata RaveTSDV, to provide a scalable and auditable technology solution for its clinical operations and data management teams.
 
“We’re proud that Medidata’s cloud-based platform is supporting Sanofi in driving the effective and high-quality delivery of new medicines to patients worldwide,” said Glen de Vries, president of Medidata. “Sanofi is an early adopter of risk-based monitoring practices and has been quick to implement TransCelerate’s recommendations on this important methodology, streamlining the way clinical trials are conducted and monitored around the world.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics